Liquidia (LQDA) EPS (Basic) Growth (1y) (2021 - 2026)
Liquidia (LQDA) EPS (Basic) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 68.42% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 5.97% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | -11.98% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | -94.11% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 2,362.50% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -21.43% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -385.71% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 72.64% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -281.82% |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 233.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 233.33% |
| Dec 31, 2025 | 136.96% |
| Sep 30, 2025 | 90.00% |
| Jun 30, 2025 | -28.95% |
| Mar 31, 2025 | -12.50% |
| Dec 31, 2024 | -9.52% |
| Sep 30, 2024 | -66.67% |
| Jun 30, 2024 | -5.56% |
| Mar 31, 2024 | -122.22% |
| Dec 31, 2023 | -366.67% |
| Sep 30, 2023 | -71.43% |
| Jun 30, 2023 | -140.00% |
| Mar 31, 2023 | 40.00% |
| Dec 31, 2022 | 60.87% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | -15.38% |
| Mar 31, 2022 | -42.86% |
| Dec 31, 2021 | 39.47% |
| Sep 30, 2021 | 65.00% |
| Jun 30, 2021 | 73.47% |